bluebird bio, Inc.
DONOR REPAIR TEMPLATES MULTIPLEX GENOME EDITING
Last updated:
Abstract:
The present disclosure provides improved multiplex genome editing compositions and methods. The disclosure further provides genome edited cells for the prevention, treatment, or amelioration of at least one symptom of a hemoglobinopathy, a cancer, an infectious disease, an autoimmune disease, an inflammatory disease, or an immunodeficiency.
Status:
Application
Type:
Utility
Filling date:
15 Feb 2018
Issue date:
26 Dec 2019